Analysts predict that bluebird bio, Inc. (NASDAQ:BLUE) will report sales of $45.34 million for the current fiscal quarter, according to Zacks. Eight analysts have provided estimates for bluebird bio’s earnings, with the lowest sales estimate coming in at $4.00 million and the highest estimate coming in at $130.60 million. bluebird bio posted sales of $19.27 […]
